Mike Matson
Stock Analyst at Needham
(2.40)
# 2,469
Out of 4,944 analysts
527
Total ratings
41.58%
Success rate
-0.07%
Average return
Main Sectors:
Stocks Rated by Mike Matson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AORT Artivion | Maintains: Buy | $32 → $45 | $43.14 | +4.31% | 18 | Aug 8, 2025 | |
| HAE Haemonetics | Maintains: Buy | $84 → $68 | $52.85 | +28.67% | 14 | Aug 7, 2025 | |
| ENOV Enovis | Maintains: Buy | $57 → $49 | $29.91 | +63.82% | 16 | Aug 7, 2025 | |
| SYK Stryker | Maintains: Buy | $442 → $448 | $378.01 | +18.52% | 9 | Aug 1, 2025 | |
| INMD InMode | Reiterates: Hold | n/a | $14.61 | - | 20 | Jul 30, 2025 | |
| ATRC AtriCure | Maintains: Buy | $44 → $45 | $36.86 | +22.08% | 35 | Jul 30, 2025 | |
| NEO NeoGenomics | Maintains: Buy | $8.5 → $8 | $6.29 | +27.19% | 26 | Jul 29, 2025 | |
| MMSI Merit Medical Systems | Reiterates: Buy | $108 | $85.98 | +25.61% | 30 | Jul 18, 2025 | |
| LUCD Lucid Diagnostics | Reiterates: Buy | $3 | $0.98 | +206.12% | 20 | Jul 16, 2025 | |
| TMDX TransMedics Group | Reiterates: Hold | n/a | $133.21 | - | 11 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $48 | $36.59 | +31.18% | 3 | Jun 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $61 | $55.18 | +10.55% | 25 | Jun 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $92.80 | - | 20 | Jun 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $115 | $102.73 | +11.94% | 30 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $68.51 | - | 21 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $12 | $7.78 | +54.24% | 19 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $64 | $51.93 | +23.24% | 26 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $42 | $20.38 | +106.08% | 23 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $51 → $41 | $29.82 | +37.49% | 17 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $38.25 | - | 21 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $155.47 | - | 25 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $4.84 | +44.63% | 20 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $112.70 | - | 5 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $246.30 | - | 11 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $122.25 | - | 9 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $258.72 | - | 10 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $102.85 | - | 26 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $288.26 | - | 14 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $42 | $16.00 | +162.50% | 2 | May 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $75 | $62.77 | +19.48% | 1 | Feb 18, 2021 |
Artivion
Aug 8, 2025
Maintains: Buy
Price Target: $32 → $45
Current: $43.14
Upside: +4.31%
Haemonetics
Aug 7, 2025
Maintains: Buy
Price Target: $84 → $68
Current: $52.85
Upside: +28.67%
Enovis
Aug 7, 2025
Maintains: Buy
Price Target: $57 → $49
Current: $29.91
Upside: +63.82%
Stryker
Aug 1, 2025
Maintains: Buy
Price Target: $442 → $448
Current: $378.01
Upside: +18.52%
InMode
Jul 30, 2025
Reiterates: Hold
Price Target: n/a
Current: $14.61
Upside: -
AtriCure
Jul 30, 2025
Maintains: Buy
Price Target: $44 → $45
Current: $36.86
Upside: +22.08%
NeoGenomics
Jul 29, 2025
Maintains: Buy
Price Target: $8.5 → $8
Current: $6.29
Upside: +27.19%
Merit Medical Systems
Jul 18, 2025
Reiterates: Buy
Price Target: $108
Current: $85.98
Upside: +25.61%
Lucid Diagnostics
Jul 16, 2025
Reiterates: Buy
Price Target: $3
Current: $0.98
Upside: +206.12%
TransMedics Group
Jun 17, 2025
Reiterates: Hold
Price Target: n/a
Current: $133.21
Upside: -
Jun 13, 2025
Reiterates: Buy
Price Target: $48
Current: $36.59
Upside: +31.18%
Jun 12, 2025
Downgrades: Hold
Price Target: $61
Current: $55.18
Upside: +10.55%
Jun 6, 2025
Reiterates: Hold
Price Target: n/a
Current: $92.80
Upside: -
May 28, 2025
Reiterates: Buy
Price Target: $115
Current: $102.73
Upside: +11.94%
May 28, 2025
Reiterates: Hold
Price Target: n/a
Current: $68.51
Upside: -
May 22, 2025
Upgrades: Buy
Price Target: $12
Current: $7.78
Upside: +54.24%
May 13, 2025
Reiterates: Buy
Price Target: $64
Current: $51.93
Upside: +23.24%
May 8, 2025
Reiterates: Buy
Price Target: $42
Current: $20.38
Upside: +106.08%
May 8, 2025
Maintains: Buy
Price Target: $51 → $41
Current: $29.82
Upside: +37.49%
Apr 30, 2025
Reiterates: Hold
Price Target: n/a
Current: $38.25
Upside: -
Apr 10, 2025
Reiterates: Hold
Price Target: n/a
Current: $155.47
Upside: -
Apr 10, 2025
Reiterates: Buy
Price Target: $7
Current: $4.84
Upside: +44.63%
Apr 8, 2025
Reiterates: Hold
Price Target: n/a
Current: $112.70
Upside: -
Apr 7, 2025
Reiterates: Hold
Price Target: n/a
Current: $246.30
Upside: -
Mar 12, 2025
Reiterates: Hold
Price Target: n/a
Current: $122.25
Upside: -
Feb 19, 2025
Reiterates: Hold
Price Target: n/a
Current: $258.72
Upside: -
Feb 7, 2025
Reiterates: Hold
Price Target: n/a
Current: $102.85
Upside: -
Jan 31, 2025
Reiterates: Hold
Price Target: n/a
Current: $288.26
Upside: -
May 4, 2021
Maintains: Buy
Price Target: $34 → $42
Current: $16.00
Upside: +162.50%
Feb 18, 2021
Maintains: Buy
Price Target: $65 → $75
Current: $62.77
Upside: +19.48%